22q11.2缺失综合征患者精神分裂症1例报告

Q4 Medicine
Sergio Cardona Bejarano MD , Lorena García-Fernández PhD MD
{"title":"22q11.2缺失综合征患者精神分裂症1例报告","authors":"Sergio Cardona Bejarano MD ,&nbsp;Lorena García-Fernández PhD MD","doi":"10.1016/j.psiq.2025.100714","DOIUrl":null,"url":null,"abstract":"<div><div>22q11.2 deletion syndrome (22q11.2DS), also known as velocardiofacial syndrome (VCFS) or DiGeorge syndrome, is a common autosomal dominant disorder caused by a microdeletion on chromosome 22, leading to a spectrum of congenital defects and neuropsychiatric manifestations, including a significantly increased risk of schizophrenia. This case report details a 23-year-old male with confirmed 22q11.2DS who presented with acute psychosis, following a history of developmental delays, attention deficit hyperactivity disorder, obsessive-compulsive disorder, and cognitive impairments. The neuropsychiatric symptoms are attributed to genetic disruptions in dopamine and glutamate pathways, notably involving the COMT and PRODH genes, which contribute to dopaminergic dysregulation and NMDA receptor dysfunction. Neuroimaging supports these findings, with structural anomalies in the prefrontal cortex and thalamus. The case exemplifies the complex interaction of genetic predisposition and environmental stressors in the onset of schizophrenia in 22q11.2DS. Early intervention targeting both genetic factors and environmental stressors is critical in managing the neuropsychiatric burden in this population, emphasizing the need for comprehensive, multidisciplinary care.</div></div>","PeriodicalId":39337,"journal":{"name":"Psiquiatria Biologica","volume":"32 2","pages":"Article 100714"},"PeriodicalIF":0.0000,"publicationDate":"2025-03-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Schizophrenia in 22q11.2 deletion syndrome: A case report\",\"authors\":\"Sergio Cardona Bejarano MD ,&nbsp;Lorena García-Fernández PhD MD\",\"doi\":\"10.1016/j.psiq.2025.100714\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><div>22q11.2 deletion syndrome (22q11.2DS), also known as velocardiofacial syndrome (VCFS) or DiGeorge syndrome, is a common autosomal dominant disorder caused by a microdeletion on chromosome 22, leading to a spectrum of congenital defects and neuropsychiatric manifestations, including a significantly increased risk of schizophrenia. This case report details a 23-year-old male with confirmed 22q11.2DS who presented with acute psychosis, following a history of developmental delays, attention deficit hyperactivity disorder, obsessive-compulsive disorder, and cognitive impairments. The neuropsychiatric symptoms are attributed to genetic disruptions in dopamine and glutamate pathways, notably involving the COMT and PRODH genes, which contribute to dopaminergic dysregulation and NMDA receptor dysfunction. Neuroimaging supports these findings, with structural anomalies in the prefrontal cortex and thalamus. The case exemplifies the complex interaction of genetic predisposition and environmental stressors in the onset of schizophrenia in 22q11.2DS. Early intervention targeting both genetic factors and environmental stressors is critical in managing the neuropsychiatric burden in this population, emphasizing the need for comprehensive, multidisciplinary care.</div></div>\",\"PeriodicalId\":39337,\"journal\":{\"name\":\"Psiquiatria Biologica\",\"volume\":\"32 2\",\"pages\":\"Article 100714\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2025-03-03\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Psiquiatria Biologica\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S1134593425000168\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"Medicine\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Psiquiatria Biologica","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1134593425000168","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0

摘要

22q11.2缺失综合征(22q11.2 ds),也称为心面疾速综合征(VCFS)或DiGeorge综合征,是一种常见的常染色体显性遗传病,由22号染色体微缺失引起,可导致一系列先天性缺陷和神经精神表现,包括精神分裂症风险显著增加。本病例报告详细介绍了一名确诊22q11.2DS的23岁男性患者,其表现为急性精神病,既往有发育迟缓、注意缺陷多动障碍、强迫症和认知障碍病史。神经精神症状可归因于多巴胺和谷氨酸通路的遗传破坏,特别是涉及COMT和PRODH基因,这有助于多巴胺能失调和NMDA受体功能障碍。神经影像学证实了这些发现,前额叶皮层和丘脑的结构异常。该病例体现了22q11.2DS中精神分裂症发病中遗传易感性和环境压力因素的复杂相互作用。针对遗传因素和环境压力因素的早期干预对于管理这一人群的神经精神负担至关重要,强调需要全面的多学科护理。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Schizophrenia in 22q11.2 deletion syndrome: A case report
22q11.2 deletion syndrome (22q11.2DS), also known as velocardiofacial syndrome (VCFS) or DiGeorge syndrome, is a common autosomal dominant disorder caused by a microdeletion on chromosome 22, leading to a spectrum of congenital defects and neuropsychiatric manifestations, including a significantly increased risk of schizophrenia. This case report details a 23-year-old male with confirmed 22q11.2DS who presented with acute psychosis, following a history of developmental delays, attention deficit hyperactivity disorder, obsessive-compulsive disorder, and cognitive impairments. The neuropsychiatric symptoms are attributed to genetic disruptions in dopamine and glutamate pathways, notably involving the COMT and PRODH genes, which contribute to dopaminergic dysregulation and NMDA receptor dysfunction. Neuroimaging supports these findings, with structural anomalies in the prefrontal cortex and thalamus. The case exemplifies the complex interaction of genetic predisposition and environmental stressors in the onset of schizophrenia in 22q11.2DS. Early intervention targeting both genetic factors and environmental stressors is critical in managing the neuropsychiatric burden in this population, emphasizing the need for comprehensive, multidisciplinary care.
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Psiquiatria Biologica
Psiquiatria Biologica Medicine-Psychiatry and Mental Health
CiteScore
0.40
自引率
0.00%
发文量
13
期刊介绍: Es la Publicación Oficial de la Sociedad Española de Psiquiatría Biológica. Los recientes avances en el conocimiento de la bioquímica y de la fisiología cerebrales y el progreso en general en el campo de las neurociencias han abierto el camino al desarrollo de la psiquiatría biológica, fundada sobre bases anatomofisiológicas, más sólidas y científicas que la psiquiatría tradicional.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信